What is ipamorelin, and why is its selectivity clinically significant
ingredients: aqua/water/eau, macadamia ternifolia seed oil, isocetyl stearoyl stearate, caprylic/capric triglyceride, glycerin, dimethicone, olea europaea (olive) fruit oil, parfum/fragrance, cetearyl alcohol, cetearyl glucoside, cetyl alcohol, stearyl alcohol, butyrospermum parkii (shea) butter, stearic acid, phenoxyethanol, caprylyl glycol, benzophenone-3, tocopheryl acetate, xanthan gum, acrylates/c10-30 alkyl acrylate crosspolymer, potassium sorbate, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, sodium hydroxide, hexylene glycol, hydroxycitronellal, disodium edta, limonene, bht, linalool, citric acid
KLOW is not an FDA-approved treatment, and no KLOW cycle has been clinically validated
Peptide Blend Vials (12 mg each): 8 weeks (~11.2 mL total): 4 vials 12 weeks (~16.8 mL total): 6 vials 16 weeks (~22.4 mL total): 8 vials Insulin Syringes (U100): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution
95% CI: 0.430.75